Effects of indeloxazine hydrochloride, a cerebral activator, on brain function in rodents

Yamamoto, 1990, Pharmacological and biochemical properties of indeloxazine hydrochloride, a new cerebral activator, Brain Dysfunct, 3, 130 Shimizu-Sasamata, 1991, Effects of indeloxazine hydrochloride on behavioral and biochemical changes in the chronic phase of focal cerebral ischemia in rats, Arch Int Pharmacodyn Ther, 314, 74 Yamamoto, 1989, Effects of a new cerebral activator, indeloxazine hydrochloride, on disturbance of learned behavior in gerbils subjected to transient occlusion of the carotid artery, Res Commun Psychol Psychiatry Behav, 14, 113 Harada, 1979, Biochemical characteristics of a potential antidepressant, 2-(7-indenyloxymethyl) morpholine hydrochloride (YM-08054-1), and its derivatives with potential antidepressant properties, Biochem Pharmacol, 28, 2645, 10.1016/0006-2952(79)90041-8 Shimizu-Sasamata, 1993, Anti-hypoxic and anti-ischemic actions of indeloxazine hydrochloride and its optical isomers: Possible involvement of cerebral energy metabolism, Arch Int Pharmacodyn Ther, 324, 33 Giurgea, 1977, Nootropic drugs, Prog Neuropsychopharmacol, 1, 235, 10.1016/0364-7722(77)90046-7 Pontecorvo, 1985, Effects of aniracetam on delayed matching-to-sample performance of monkeys and pigeons, Pharmacol Biochem Behav, 22, 745, 10.1016/0091-3057(85)90523-4 Nakajima, 1986, Pharmacological study of aniracetam. VI. Effects of aniracetam on muscarinic acetylcholine receptors in the rat hippocampus, Jpn Pharmacol Ther, 14, 85 Yoshizaki, 1986, Pharmacological study of aniracetam. V. Inhibitory effect of aniracetam on scopolamine induced increase of sodium-dependent high affinity choline uptake into rat hippocampus, Jpn Pharmacol Ther, 14, 75 Ohtomo, 1991, Clinical efficacy of aniracetam on psychiatric symptoms in patients with cerebral vascular disease, J Clin Exp Med, 156, 143 Ohtomo, 1986, Clinical evaluation of YM-08054 (indeloxazine) in the treatment of cerebrovascular disorder, Igaku No Ayumi, 136, 535 Nomura, 1982, A new behavioral test for antidepressant drugs, Eur J Pharmacol, 83, 171, 10.1016/0014-2999(82)90248-5 Jarvik, 1967, An improved one-trial passive avoidance learning situation, Psychol Rep, 21, 221, 10.2466/pr0.1967.21.1.221 Yamamoto, 1988, Effects of a new TRH analogue, YM-14673, on a passive avoidance test as possible criterion of improvement in cognitive disturbance in rodents, Naunyn-Schmiedeberg's Arch Pharmacol, 338, 262, 10.1007/BF00173398 Porsolt, 1977, Depression: A new animal model sensitive to antidepressant treatment, Nature, 266, 730, 10.1038/266730a0 Malinge, 1988, Additive effects of clonidine and antidepressant drugs in the mouse forced-swimming test, Psychopharmacology, 96, 104, 10.1007/BF02431541 Rogoz, 1989, Antidepressant activities of WEB 1881, a new nootropic agent, Pol J Pharmacol Pharm, 41, 439 Bhattacharya, 1989, Effect of piracetam, a nootropic agent, on rat brain monoamines and prostaglandins, Indian J Exp Biol, 27, 261 Yamamoto, 1993, Effects of indeloxazine hydrochloride, a cerebral activator, on passive avoidance learning impaired by disruption of cholinergic transmission in rats, Neuropharmacology, 31, 695, 10.1016/0028-3908(93)90083-F Williams, 1989, Management of depression in the elderly, Primary Care, 16, 451, 10.1016/S0095-4543(21)01100-3 Yamamoto, 1990, Effects of a new cerebral activator, indeloxazine hydrochloride, on electroencephalogram and disturbed learning behavior in rodents, Res Commue Psychol Psychiatry Behav, 15, 1 Kometani, 1991, Effect of oxiracetam on cerebrovascular impairment in rats, Arzneim Forsch Drug Res, 41, 684 Cumin, 1982, Effects of the novel compound aniracetam upon impaired learning and memory in rodents, Psychopharmacology, 7, 104, 10.1007/BF00432244